ABSTRACT The chloride self-exchange,flux across the human red cell membrane is rapidly and reversibly inhibited by 10 -4 M furosemide, a potent chloruretic agent. Furosemide reduces the chloride flux at all chloride concentrations and increases the cellular chloride concentration at which the flux is half-maximum. Kinetic analysis of the flux measurements made at several furosemide and chloride concentrations yields a pattern of mixed inhibition with a dissociation constant for the inhibitor-transport mechanism complex of 5 × 10 -s M. From this pattern of inhibition and other observations, including that the percent inhibition is independent of pH (range 5.6-8.9), we conclude that the anionic form of furosemide interacts primarily with the chloride transport mechanism at a site separate from both the transport site and the halide-reactive modifier site.
INTRODUCTION
Furosemide ( Fig. 1) is a rapidly acting, potent diuretic that is commonly used in clinical medicine. Its administration causes a marked increase in the excretion of sodium, potassium, calcium, magnesium, chloride, phosphate, and water by the' kidney in rats, dogs, and man (15) . The major site of furosemide's diuretic effect is the ascending limb of Henle's loop (8) . Because Hook and Williamson (21) had found that furosemide decreased the ATPase activity in microsomal preparations from rat kidney, and Sachs (26) had found that furosemide decreased the ouabain-sensitive and insensitive sodium permeability in human red blood cells, the mechanism of action of this drug was thought to be an inhibition of cation transport.
More recently, attention has been focused on the inhibitory effects of furosemide on the transport of inorganic anions. Furosemide was one of numerous inhibitors that decreased phosphate tracer efflux across intact human red blood cells (14) . The [32P]phosphate efflux in solutions with 1 mM total phosphate, pH 7.35, at 37°C was inhibited 50% by 5 × 10 -4 M furosemide. This inhibition was reversible and noncompetitive. Recently Burg and Green (3) found that chloride was actively transported out of the lumen of perfused tubules isolated from the rabbit kidney. Furosemide (10 -5 M) in the lumen of the thick ascending limb of Henle's loop decreased the electrical potential difference from +5 mV (lumen positive) to near zero and decreased the net flux of NaCI from the lumen (4) . This observation is consistent with active electrogenic transport of chloride THE JOURNAL OF GENERAL PHYSIOLOGY • VOLUME 68, 1976 " pages 583-599 583 which is inhibited by furosemide and passive diffusion of Na from lumen to peritubular fluid. Furosemide can cause a 50% reduction in the short circuit current in frog cornea (6) , in which active chloride transport accounts for 90% of the short circuit current (31) . In man and dogs systemic furosemide decreased the volume and the bicarbonate concentration of the fluid collected from cannulated pancreatic ducts (25, 16 ). An anion exchange mechanism has been reported in mammalian pancreatic ducts (24) ; the observed decrease in bicarbonate concentration of pancreatic fluid caused by furosemide may be a result of an inhibited anion exchange mechanism.
In this paper we report the results of our studies on the effect of furosemide on the chloride transport system in the human red blood cell. The chloride selfexchange transport in erythrocytes shows saturation with increasing chloride concentration, competitive inhibition by other inorganic anions, noncompetitive inhibition by certain organic compounds, a characteristic pH dependence (19) , and a high apparent activation energy (13) . This anion exchange mechanism appears to depend upon the integrity of an intrinsic erythrocyte membrane protein (5, 20) and can be described by a titratable carrier model (17) . We studied the interaction of furosemide with the red cell anion exchange mechanism in an effort to increase our understanding of both the drug's mode of action and the chloride transport mechanism in human red blood cells.
MATERIALS AND METHODS
The methods are fully described in Gunn et al. (19) ; a brief summary is given here. Media with the following millimolar concentrations were prepared from reagent grade chemicals: chloride medium-140 NaCl, 5 KC1, 1.5 CaCIz, 1.0 MgCiz, 5 d-glucose, and 27 glycylglycine; acetate medium-140 Na-acetate, 5 K-acetate, 1.5 Ca-(acetate)2, 1.0 Mg-(acetate)2, 5 d-glucose, and 27 glycylglycine; nystatin medium-25-600 KC1, 10 NaCI, and 27 sucrose. Furosemide, a white powder received as a gift from Hoechst Parmaceuticals, Inc., (Cincinnati, Ohio) was made into a 50 mM stock solution in 0.1 N KOH. Aliquots of the stock solution were added to the appropriate medium before final adjustment of the pH at 0°C. Nystatin (E. R. Squibb and Sons, Inc., Princeton, N.J.) was dissolved in dimethyl sulfoxide to make a stock solution.
Red blood cell suspensions were prepared from freshly drawn heparinized whole blood from one of the researchers (P. C. B.). The red cells were separated from the plasma and buffy coat, washed in 170 mM NaC1, titrated to the desired pH with CO2 and bicarbonate at 0°C, and then washed several times in cold medium until the chloride was in steady state between cells and solution. Then nnC1 (ICN Pharmaceuticals, Inc., Cleveland, Ohio, 10/zi of 462/zCi/ml) was added to the suspension and allowed to equilibrate. This suspension was packed in thin nylon tubes and centrifuged to separate cells from medium. 0.25 g of packed cells was added to 25 ml of cold medium at time zero in a thermostated chamber. The extracellular fluid was sampled by the rapid filtration technique of Dalmark and Wieth (13) . An "infinity" sample was taken from this suspension after the tracer had reached a steady-state distribution.
A semilog graph of the fraction of tracer remaining in the cells as a function of time was a straight line whose slope is the rate constant. The product of this rate constant and the intracellular chloride concentration in milliequivalents per kilogram cell solids is the self-exchange flux in milliequivalents per (kilogram cell solids-minute). The intraceilular chloride concentration for each flux was calculated from the steady-state ratio of intracellular to extracellular n6Cl activity (re1) times the measured extraceUular chloride concentration and the kilograms cell water per kilogram cell solids (determined by drying cells to constant weight). Duplicate flux measurements were performed for each set of conditions. The average range between duplicate measurements was 5% of the flux magnitude. The nystatin method of equilibrium dialysis of red cells was used to alter, the intracellular chloride concentration in one series of experiments, (7, 10) .
RESULTS

Furosemide Inhibition of Chloride Self-Exchange Flux
The self-exchange of chloride isotopes across red blood cells was measured in the presence of graded concentrations of furosemide at pH 7.80, 0°C. The red cells were first suspended in chloride medium with a given concentration of furosemide, loaded with radioactive 36C1, and injected into a nonradioactive chloride medium with the same furosemide concentration. The results are shown in Fig. 2 . The self-exchange flux was inhibited 50% by 2 × 10 -4 M furosemide. In 5 × 10 -n M furosemide the residual insensitive flux was only 12 meq/(kg cell solids, min) or 1.6% of the control flux value. Both the rapidity with which furosemide inhibited chloride self-exchange and the reversibility of its effect were shown by the experiments presented in Fig. 3 . First the efflux of chloride from cells prewashed with solutions containing 5 × 10 -4 M furosemide was compared with the efflux of cells without prior exposure to furosemide. Both types of cells were injected into chloride media containing 5 × 10 -4 M furosemide. The efflux rates were identical and the efflux of the cells which had no prior exposure to furosemide followed the same first-order kinetics. This indicates that the same level of inhibition was attained before the first sample (at 6 s) by the reaction of the cells with the furosemide in solution. The reversibility of inhibition was demonstrated by prewashing cells in 10 -n M furosemide then washing an aliquot of cells six times in 4 vol of drug-free medium before measuring the efflux. The rate constant for the control flux was 0.053 s -1 and for the flux in 10 -3 M furosemide 0.0051 s -1 while the efflux rate coefficient of the pretreated cells washed in furosemide-free medium was 0.050 s -1. This value was not significantly less than the control. 3. Effects of furosemide on the efflux of cellular 36C1. The rate constant for the efflux of chloride tracer was determined from the slope of the appearance of tracer in the extracellular compartment (1-at~a=, where at is the specific activity at time t; and a= is the specific activity at isotopic steady state) as a function of time in seconds. The plot shows first-order kinetics for the tracer efflux of control cells (O), cells treated with furosemide (10 -3 M) then washed in drug-free medium (Q), cells preincubated and measured in furosemide (5 x 10 -4 M) (O), and drug-free cells that were first exposed to furosemide (5 × 10 -4 M) at the beginning of the efflux measurements (I). The efflux measurements were made in chloride medium, pH 8.00, 0°C. The slope of the graph was determined by linear regression analysis.
The Effect of Cellular Chloride Concentration on Furosemide Inhibition
The chloride self-exchange flux of red cells has been shown to depend upon the cellular chloride concentration (19, 9) . Two methods were used to alter the intracellular chloride concentration of erythrocytes. In the first, the red cells were washed repeatedly in Na-acetate medium to which ammonium chloride had been added to achieve the desired chloride concentration. The high permeability of ammonia and carbon dioxide combined with the rapid chloridebicarbonate exchange permitted the ammonium chloride rapidly to distribute itself across the red cell membrane. Once the chloride had reached steady state between the cells and the medium, the cells were treated with furosemide and the tracer efflux into the same Na-acetate-NH4Cl medium was measured. Using a second method we looked for an effect of ammonium and acetate ions on either furosemide or the chloride transport mechanism. In this method (7, 10) nystatin was used to reversibly increase red cell permeability while the ionic content was changed (20-600 mM KCI, 10 mM NaC1). Once the cells were in steady state with the new medium, the nystatin was washed off. These cells were then treated with furosemide and the chloride content and tracer efflux measured. (9) with a maximum near 150 mM chloride and a decline in the flux value with further increases in the cellular chloride concentration. The curve in the presence of furosemide has the same shape as the curve found in Na-acetate-NH4Cl medium. A comparison of Fig. 4a and b shows that the magnitude of the chloride self-exchange flux is lower in the Na-acetate-NH4C1 medium due to the noncompetitive inhibition of the chloride flux by acetate (19) . However, the calculated maximum chloride flux (see below) from the data in Fig. 4a is the same as that observed in Fig. 4b . Furthermore, the presence of furosemide (5 × 10 -4 M) when studied by either method prevented the decrease in the self-exchange flux at high cellular chloride concentrations which was observed in the absence of furosemide with both methods (19, 9) . analogy to enzyme kinetic systems this figure indicates that furosemide caused a mixed-type (competitive and noncompetitive) inhibition (28) . In a Dixon plot (Fig. 6) , the lines through the data points for each of three chloride concentrations intersect at a point above the abscissa and to the left of the ordinate, again compatible with a mixed type of inhibition (28) . The point of intersection of these lines corresponds to the KI (dissociation constant of the t These values from a statistical evaluation of data at only low CI concentrations (where selfinhibition is not prominent ) are different from the observed maximum flux of 460 and concentration of chloride at which the flux is half of 460, namely 35 mM, as reported earlier (19) . We believe that the values in the text more accurately reflect the underlying phenomena of the transport system than the simple observables reported earlier. . Dixon plot. The reciprocal of the chloride self-exchange flux is graphed as a function of the furosemide concentration at three cellular chloride concentrations. In this graph the Na-acetate-NH4Cl medium method was used to alter intracellular chloride at pH 7.80, 0°C. The lines were drawn by eye. The pattern of the graph is compatible with mixed-type inhibition and the lines intersect at a point equal to the negative of the dissociation constant (K1) which is 5 × 10 -5 M for furosemide. inhibitor-enzyme complex) which was 5 × 10 -5 M in this case. The deviation from linearity seen at the lowest chloride concentration (26 mM) and the highest furosemide concentration reflects the presence of the furosemide-insensitive chloride flux which becomes a greater portion of the measured flux under these conditions. Because of this furosemide-insensitive flux, the reciprocal of the flux has a maximum value which the lines on the Dixon plot must asymptotically approach at high drug concentrations.
The pH and Temperature Dependence of the Chloride Self-Exchange Flux in the Presence of Furosemide
Two characteristic features of the chloride transport system in red blood cells are the decreasing self-exchange flux at pH values below 7.8 at 0°C (19, 9) and the high apparent activation energy of 30 kcal/mol (12, 13, 9) . These parameters were restudied in the presence of 5 × 10 -4 M furosemide (approximately 75% inhibition of the control flux) to determine if changes in pH or temperature would alter the effectiveness of furosemide inhibition.
The pH dependence of the chloride self-exchange flux was determined in red cells equilibrated at 0°C in chloride medium at the desired pH value. Fig. 7 shows the relationship of the self-exchange flux to the pH of the medium for uninhibited cells and cells inhibited by 5 × 10 -4 M furosemide. The curves for both conditions are concave with a maximum around pH 7.8. The percent inhibition of the control flux at the different pH values was nearly constant (75-80%) over this pH range (5.6-8.9). Thus, the reaction of the transport mechanism with hydrogen ions which causes inhibition did not significantly alter the inhibitory effect of furosemide. This observation is consistent with either a model in which H30 + and furosemide compete for a common locus or a model in which they have separate loci and independent inhibitory actions. Theoretically, in both of these models the fractional inhibition caused by one inhibitor is dependent upon the concentration of the second inhibitor, because the reactions are reversible and obey the law of mass action (reference 18, p. 322). However, under the experimental conditions of Fig. 7 with a fixed furosemide concentration, very little change in the percent inhibition would occur if either model were operative. 2 Therefore the relationship between the sites of H30 + inhibition and self-exchange between 0 ° and 38°C with a flow tube apparatus and may reflect an increase of K1/2 with temperature. Alternatively, we may have introduced a systematic error at the highest temperatures due to the very rapid rate of
k2H)/(l + kaH + k~F + kak4H'F). If k4 is small [k4 = HFE/(HE.F) = (HFE-CI)/(HE-CI.F)]
, then the above calculation holds for a single site; and if not, a reasonable guess is that k, = kn or that the reaction of H or CI with their separate sites does not affect the binding affinity for furosemide (F) at its separate independent site. If so, then under the same experimental conditions as above, vHv/vn = 0.75 at pH 5.6 where k2H = 0.25, kaF = 0.34 and k2ka/-/.F = 0.085 and vn~/Vn = 0.75 at high pH where k~t--/ = k~I-IK,F = O.
Thus under these experimental conditions both the single-site and the two-site models predict a pH-independent fractional inhibition by furosemide and cannot be distinguished by these data. Since at very low pH other transport mechanisms come into play, we cannot be sure that at even more extreme conditions these two model mechanisms can be separated by further experiments. sampling for these data points. In our data the slope of the graph through the lower points yields an apparent activation energy of 29 kcal/mol for both the control and the furosemide-inhibited chloride flux. Thus, there was no unusual temperature sensitivity of the inhibition of the chloride flux by furosemide. sensitive by Deuticke and Gerlach (14) . In their study the furosemide concentration required for 50% inhibition of [a2p]phosphate efflux was 5 × 10 -4 M. This value is only 2.5 times the concentration required to inhibit by 50% the chloride self-exchange flux reported in this study under quite different experimental conditions. Deuticke and Gerlach measured phosphate self-exchange at 37°C at pH 7.35 in Locke's solution containing 1 mM phosphate. The chloride and bicarbonate ions in Locke's solution are inhibitors (probably competitive) of divalent (29) and monovalent inorganic anion transport (19, 11) . These inhibitors would decrease the inhibitory effect of furosemide if they reacted with the anion transport mechanism at a common site. Other differences, e.g., temperature and degree of carrier saturation, may also play a~ role in the slight difference in the concentration of furosemide required for 50% inhibition in these two systems.
Furosemide interacts with the red cell very rapidly and reversibly. In Fig. 3 one can see that the onset of inhibition by this drug is less than 6 s at 0°C. The rapidity of this effect implies that furosemide acts at a superficial site on the cell. Since furosemide is a large organic acid (pKa = 3.9) one would not expect it to rapidly cross the cell membrane. For comparison parasulfamoyl benzoic acid which is similar to a part of the furosemide molecule (see Fig. 1 ) does not cross the ox red cell membrane to any significant degree (1). Thus we would not expect the charged form (see below) of the larger furosemide molecule to cross into the red cell within 6 s. Furosemide's effect on red cell chloride transport was reversed by washing the cells six times with drug-free medium. The relative ease of reversing the inhibition of this drug also suggests that furosemide's action is on the membrane surface. So while furosemide has been shown to inhibit glycolysis in cell-free preparations (23) , it appears to inhibit anion transport in red cells at the level of the cell membrane, and most likely the outer surface of this membrane.
Furosemide has a negatively charged carboxyl group at neutral pH. We measured the effect of altering the pH of the medium on the inhibitory action of furosemide on the chloride self-exchange flux. Over a pH range of 5.6-8.9 (Fig.  7) the percent of inhibition of chloride flux caused by 5 x 10 -4 M furosemide was nearly constant (75-80%). Since the concentration of uncharged furosemide varied by a factor of 10 n while the negatively charged form was nearly constant, this result indicates that the anionic form of the drug is the active inhibitor. We cannot say whether the neutral form of the drug is also an inhibitor.
The kinetic analysis of the experimental data in this paper reveals four points. In the absence of acetate, that is in media containing only chloride and furosemide anions, (a) the dose-response curve shows an apparent stoichiometry of more than one furosemide molecule inhibiting each transport unit, and (b) the curve of the chloride flux graphed against chloride concentration (Fig. 4b ) is complex and above a certain concentration, chloride inhibits its own flux. In the presence of acetate anions, (c) the stoichiometry for furosemide inhibition of transport units is 1:1, and (d) furosemide behaves as a mixed-type inhibitor of the chloride self-exchange system (Figs. 5 and 6 ). The analyses supporting points (a) and (c) are presented below and in Fig. 9 .
Dalmark (11) has made a detailed study of the chloride saturation curve (Fig.  4b) with particular attention to the influences of other halide anions on the selfinhibition by chloride. He has proposed that the chloride transport mechanism has two anion binding sites, one for anion translocation and another for noncompetitive inhibition of translocation. Dalmark observed chloride self-exchange between 10 and 400 mM chloride in the presence of other halides (10-300 mM) in cells prepared by the nystatin method, and found that halides decreased the calculated maximum flux, increased the K~/2, and decreased the chloride self-inhibition. He concluded first that fluoride, bromide, and iodide act both as competitive'and noncompetitive inhibitors of the chloride carrier, and are able to compete with chloride at both of the proposed anion binding sites (transport site = Cl~; modifier site = Cl2), and second, that the binding of another halide on the noncompetitive modifier site (Cl2 site) prevented chloride from binding there and prevented chloride from inhibiting its own flux.
In most of the experiments in our study, chloride concentration was altered in cells by using an Na-acetate-NH4Cl medium. Acetate anions are noncompetitive inhibitors of chloride self-exchange flux (19) , and 141 mM acetate almost completely blocks chloride self-inhibition (see Figs. 5 and 6 in reference 19) . Acetate, therefore, behaves like the halides as a competitor with chloride at the modifier (Cl2) site which is responsible for self-inhibition. In the presence of acetate, the chloride self-exchange flux follows more closely the equations of MichaelisMenten kinetics, reflecting mainly the characteristics of the transport (Cll) site.
Thus the action of acetate simplifies the analysis of furosemide inhibition (see Appendix).
The stoichiometry of the reaction between furosemide molecules and the chloride transport mechanism can be surmised by graphing a rearrangement of the Michaelis-Menten kinetic equations in which the slope of the plot indicates the number of molecules of inhibitor acting to inhibit each carrier unit (Fig. 9 ) (22) . The slope in this graph for furosemide inhibition in the absence of acetate (data from Fig. 2 ) is 1.36, which indicates that the interaction of more than one furosemide with each transport unit is required for inhibition. When one uses the data from Fig. 6 (Dixon plot, CI = 146 raM) where furosemide inhibition is studied in the presence of acetate, the slope of the graph on this plot is 1.03. Thus, furosemide in the presence of acetate requires only one molecule of inhibitor per transport unit, but in the absence of acetate, more than one furosemide molecule binds to each transport unit.
The kinetic analyses in Figs. 5 and 6 indicate that furosemide in the presence of 141 mM acetate behaves as a mixed-type inhibitor of the chloride selfexchange transport system. This result appears to be similar to the halide inhibition of chloride transport reported by Dalmark (11) ; however, the following comparison of results obtained in the absence and presence of acetate in the experimental medium shows this similarity to be illusory.
The apparent similarity between the action of furosemide and the halides is the observation that in the absence of acetate they both block the self-inhibition by chloride (Fig. 4b in this paper and Figs. 2 and 3 in reference 11 ). In analogy with the halides and when one considers the two sites proposed by Dalmark, furosemide could compete with chloride at Cl~ and Cl2 to give, respectively, competitive and noncompetitive inhibition as seen with iodide, bromide, and fluoride. The stoichiometry of more than one furosemide molecule per transport unit is consistent with this possibility. In the presence of acetate, however, furosemide also behaves kinetically as a mixed-type inhibitor and requires only one molecule to inhibit each chloride transport unit. Therefore, competition between furosemide and chloride at two sites, Cl~ and Cl2, is untenable. Competition at only Cll would not produce mixed-type inhibition but pure competitive inhibition, so exclusive reaction at this site may be removed from consideration. We have argued that acetate competition with chloride occurs at the Cl2 site and it does not seem possible that acetate competition at Cl~ could block furosemide competition at Cll to leave it only acting at Cl2. We therefore must reject the notion that furosemide reacts with Cll and Cl2 as Dalmark proposed for halides and we must postulate a third site, F~, which is not the chloride transport site and not the second halide site but which is involved in inhibition by furosemide.
The reaction scheme for mixed-type (competitive and noncompetitive) inhibi- (22) the data of the dose-response curve were replotted as the log of the (control flux/inhibited flux)-t vs. the log of the furosemide concentration. The slope of this plot indicates the number of molecules of inhibitor needed to inhibit one unit of the transport mechanism. The solid line represents the data from Fig. 2 for furosemide in the absence of acetate and has a slope of 1.36. The broken line is from the data shown in Fig. 6 , chloride concentration 146 raM, for furosemide in the presence of 141 mM acetate and has a slope of 1.03. In a separate experiment using 5 x 10 -~, 2 x 10-*, and 5 x 10 -4 M furosemide, the slope in media without acetate was 1.23 while when 141 mM NH,-acetate was included the slope was 0.96. Acetate, therefore, reduces the stoichiometry of the inhibition of chloride flux by furosemide to 1:1.
tion by an inhibitor acting at a single site (F1) is diagrammed as follows (27) 
E + I . KI ~ IE + S (aKs') IES ES + I ~agi.~. IES
The inhibitor, I, binds noncompetitively to the enzyme, E, and in doing so alters the affinity, Ks, of the enzyme for the substrate by a factor a and thus competi-tively reduces the appearance of the end product, P, (in this case the transported anion). Thus furosemide can cause a mixed type of inhibition by binding to the chloride transport unit at a single modifier site, F1, discrete from the transport site. The molecular mechanism by which the affinity of the transport site, Cll, is changed is not clear. Two possibilities are that furosemide binding to the F1 site increases local negativity which reduces the chloride concentration at the transport site; and, alternatively, that the binding to F1 decreases the chloride affinity through an allosteric conformational change at the Cll site. Furosemide apparently can also react with the Cl2 site. As pointed out earlier, the observation that acetate blocks chloride self-inhibition implies that acetate causes its noncompetitive inhibition at the Cl2 site. When this conclusion is coupled with the observation that the stoichiometry of furosemide inhibition is reduced from 1.36:1 to 1.03:1 by acetate, one easily and, we believe, correctly is led to conclude that the acetate-inhibitory site and the second site of furosemide binding are the same, namely the C12 site. We therefore believe that furosemide reacts with two nontransport sites on the transport mechanism and that acetate can displace furosemide at one of these sites (see Appendix for this model).
In conclusion, we believe that the negatively charged form of furosemide inhibits the red cell chloride flux by reacting with the transport mechanism at two sites. One (C/2) is identical with the site at which chloride can cause selfinhibition. At the second site (F0 furosemide noncompetitively blocks chloride transport and alters the affinity of chloride for the transport site (Cl0 to produce the pattern of mixed-type inhibition.
APPENDIX
From Fig. 9 and for the reasons outlined in the Discussion, it appears that furosemide binds to two nontransport sites on the transport unit. At one of these sites furosemide is displaced by acetate. This is the Cl2 site which is complexed to the inhibitor when I stands to the right of E: El. The FI site is complexed when I stands to the left of E: IE.
Although these sites may only be on the outside surface of the cell, the use of an asymmetric model and inclusion of the distribution of carriers between the inside and outside would introduce unwarranted complications at the present level of our knowledge. The analysis has, therefore, been restricted to a single set of reactions and the resulting parameters are, of course, only apparent dissociation constants. The kinetic model and equations for this situation are given below. Kt was determined to be 5 x 10 -5 M from the Dixon plot; a comparable value of 7.7 x 10 -5 M was obtained from the Lineweaver-Burk plot. The coefficient a has a value of 2.44 from the data on the Lineweaver-Burk plot and 2.64 from the data on the Dixon plot. The coefficient/3 even in the absence of acetate must have a value of at least 100 for the 12 term in the above equations to be less than 10% of the linear term in I. This will permit the graph in Fig. 9 of the data obtained in the absence of acetate to appear linear. Furthermore, by using /3 = 100 the slope of the calculated line will be 1.25. Thus both the observed linearity (12 term small) and slope greater than unity (very close to the 1.36 and 1.30 values found by experiment) can be met having/3 = 100. If one uses a larger value of /3 = 1,000 for the experiments in the presence of acetate, one calculates a slope of 1.03, the same as that found by experiment. In addition, this larger value of/3 is required for the Dixon plot (Fig. 6 ) to be linear up to furosemide concentrations of 10 -3 M.
Ks
We have neglected the form EI (inhibitor bound only to the nontransport C12 site) in the above model since/3 is estimated to be so much greater than tx. If/3 = 100, EI will be only 1% of the free E form at 5 x 10 -4 M furosemide, while the amount oflE (inhibitor bound only to the FI site) will be equal to that of the free E form. If/3 = 1,000 the EI complex is only 0.1% of the free E form and contributes even less. The inclusion of the E1 complex would therefore complicate the equations without illuminating the mechanisms. Practically speaking, the C12 site is never complexed with furosemide unless the F1 site is already complexed with another furosemide.
